Renovaro, Inc. is a pre-clinical stage biotechnology company, which engages in the development of genetically modified cellular and immune-therapy technologies used for the treatment of infectious diseases and cancer. The company is headquartered in Los Angeles, California and currently employs 25 full-time employees. The company went IPO on 2014-11-18. The firm is engaged in harnessing advanced computational biology and AI/machine learning to accelerate drug discovery, diagnostics and strengthen biosecurity capabilities. From high-resolution phenotyping to predictive disease modeling, the Company is pioneering a new era of precision diagnostics-where early detection, patient stratification, and therapeutic targeting converge into a single, adaptive platform. These are designed to transform clinical decision-making, reduce time-to-treatment, and unlock previously inaccessible insights from biological data. Its proprietary platforms in translational analytics, in vivo modeling, and machine vision-accelerating biomarker discovery and therapeutic development in precision neurology and infectious disease.
RENB stock price ended at $0 on Tuesday, after dropping NaN%
On the latest trading day Mar 24, 2026, the stock price of RENB fell by NaN%, dropping from $NaN to $NaN. During the session, the stock saw a volatility of NaN%, with prices oscillating between a daily low of $NaN and a high of $NaN. On the latest trading day, the trading volume for RENB decreased by -- shares, aligning with the declining prices, which may indicate weakening market confidence in the near term. In total, -- shares were traded, with a market value of approximately --.
RENB Technical Signals
Technical Signals Summary
Buy Signals 0
Neutral Signals 7
Sell Signals 0
Strong Sell
Sell
Neutral
Buy
Strong Buy
RENB currently exhibits 0 buy signals and 0 sell signals. The stock has been in an downtrend since --, with a total price change of -- during this period. Overall, the technical indicators point to a Neutral outlook for the mid-term.
Bullish/Bearish Signals for RENB
Our algorithms analyze key indicators like moving averages, RSI, MACD, and trading volume to generate bullish and bearish signals for RENB. These insights help you make informed investment decisions.
Follow-Up Questions
How do technical analysis indicators apply to RENB?
According to technical analysis, Lunai Bioworks Inc has an aggregate signal of Neutral. Lunai Bioworks Inc has 0 Buy signals, 7 Neutral Signals and 0 sell signals.
What is the RSI for Lunai Bioworks Inc?
The RSI for Lunai Bioworks Inc is currently 0, indicating a neutral condition
What is Lunai Bioworks Inc price for the next 12 months?
Lunai Bioworks Inc RENB price for the next 12 months is estimated at $0.
How high is Lunai Bioworks Inc expected to go?
According to wall street analysts, Lunai Bioworks Inc is expected to reach a high forecast of $0.